Mckesson Corp

More Details of McKesson Corp Company

McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.

Company Info

Ticker SymbolMCK

Company nameMcKesson Corp

IPO dateNov 10, 1994

Founded at1994

CEOMr. Brian Scott Tyler, Ph.D.

Number of employees43000

Security typeOrdinary Share

Fiscal year-endNov 10

Address6555 State Highway 161

CityIRVING

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code75039

Phone19724464800

Websitehttps://www.mckesson.com/

Ticker SymbolMCK

IPO dateNov 10, 1994

Founded at1994

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

47.46K

-33.00%

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

--

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+14.90%

Ms. Leann B. Smith

Chief Human Resources Officer, Executive Vice President

2.80K

+166.41%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.54K

--

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Mr. Dominic J. Caruso

Independent Director

349.00

--

Mr. James H. Hinton

Independent Director

--

Dr. Richard H. Carmona, M.D.

Independent Director

--

Mr. Kevin M. Ozan

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

47.46K

-33.00%

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

--

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+14.90%

Ms. Leann B. Smith

Chief Human Resources Officer, Executive Vice President

2.80K

+166.41%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.54K

--

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Revenue Breakdown

Currency: USDUpdated: Fri, Feb 21

FY2020

FY2019

No Data

By RegionUSD

Name

Revenue

Proportion

United States

192.71B

83.41%

Foreign

38.34B

16.59%

By Business

By Region

No Data

Shareholding Stats

Updated: Thu, May 15

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.42%

BlackRock Institutional Trust Company, N.A.

5.25%

State Street Global Advisors (US)

4.55%

MFS Investment Management

3.63%

JP Morgan Asset Management

2.45%

Other

74.70%

Shareholders

Proportion

The Vanguard Group, Inc.

9.42%

BlackRock Institutional Trust Company, N.A.

5.25%

State Street Global Advisors (US)

4.55%

MFS Investment Management

3.63%

JP Morgan Asset Management

2.45%

Other

74.70%

Shareholder Types

Shareholders

Proportion

Investment Advisor/Hedge Fund

40.09%

Investment Advisor

36.98%

Pension Fund

2.98%

Hedge Fund

2.80%

Research Firm

2.51%

Bank and Trust

2.25%

Sovereign Wealth Fund

1.86%

Family Office

0.50%

Family Office

0.41%

Other

9.61%

Institutional Shareholding

Updated: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2828

112.62M

89.86%

-4.48M

2024Q4

2760

112.22M

89.53%

-6.16M

2024Q3

2646

112.88M

88.88%

-6.35M

2024Q2

2612

114.72M

88.46%

-4.02M

2024Q1

2547

114.60M

88.11%

-6.25M

2023Q4

2490

116.65M

88.75%

-6.75M

2023Q3

2349

117.73M

88.45%

-6.84M

2023Q2

2305

118.79M

88.02%

-5.64M

2023Q1

2246

120.64M

88.65%

-5.49M

2022Q4

2221

123.13M

89.84%

-7.90M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

11.83M

9.44%

-161.20K

-1.34%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

6.58M

5.25%

-170.33K

-2.52%

Dec 31, 2024

State Street Global Advisors (US)

5.71M

4.56%

-170.27K

-2.90%

Dec 31, 2024

MFS Investment Management

4.66M

3.72%

-221.51K

-4.54%

Dec 31, 2024

JP Morgan Asset Management

3.16M

2.52%

+192.41K

+6.48%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

2.85M

2.27%

+222.50K

+8.48%

Dec 31, 2024

Geode Capital Management, L.L.C.

2.66M

2.13%

+10.02K

+0.38%

Dec 31, 2024

Putnam Investment Management, L.L.C.

2.34M

1.87%

+213.75K

+10.06%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

2.11M

1.68%

-176.84K

-7.75%

Dec 31, 2024

Boston Partners

1.10M

0.87%

+216.43K

+24.60%

Dec 31, 2024

Related ETFs

Updated: Fri, Jun 6

Name

Proportion

Segall Bryant & Hamill Select Equity ETF

7.64%

First Trust Consumer Staples Alphadex Fund

4.98%

VanEck Retail ETF

4.89%

VanEck Pharmaceutical ETF

4.34%

Alger 35 ETF

4.33%

Texas Capital Texas Equity Index ETF

4.23%

iShares US Consumer Staples ETF

4.18%

Janus Henderson US Sustainable Equity ETF

3.69%

JPMorgan Healthcare Leaders ETF

3.53%

Putnam Focused Large Cap Value ETF

3.04%

Segall Bryant & Hamill Select Equity ETF

Proportion7.64%

First Trust Consumer Staples Alphadex Fund

Proportion4.98%

VanEck Retail ETF

Proportion4.89%

VanEck Pharmaceutical ETF

Proportion4.34%

Alger 35 ETF

Proportion4.33%

Texas Capital Texas Equity Index ETF

Proportion4.23%

iShares US Consumer Staples ETF

Proportion4.18%

Janus Henderson US Sustainable Equity ETF

Proportion3.69%

JPMorgan Healthcare Leaders ETF

Proportion3.53%

Putnam Focused Large Cap Value ETF

Proportion3.04%

Dividend

A total of 1.45B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 30, 2025

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Apr 01, 2025 going ex on Mar 03, 2025

Mar 03, 2025

Apr 01, 2025

Mar 03, 2025

Oct 31, 2024

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 02, 2025 going ex on Dec 02, 2024

Dec 02, 2024

Jan 02, 2025

Dec 02, 2024

Aug 01, 2024

MCK.NB Final Cash Dividend of gross USD 0.71 paid on Oct 01, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Oct 01, 2024

Aug 30, 2024

Apr 24, 2024

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jul 01, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jul 01, 2024

Jun 03, 2024

Feb 01, 2024

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Apr 01, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Oct 26, 2023

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jan 02, 2024 going ex on Nov 30, 2023

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 24, 2023

MCK.NB Final Cash Dividend of gross USD 0.62 paid on Oct 02, 2023 going ex on Aug 31, 2023

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

Apr 27, 2023

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Jul 03, 2023 going ex on May 31, 2023

Jun 01, 2023

Jul 03, 2023

May 31, 2023

Jan 26, 2023

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Apr 03, 2023 going ex on Feb 28, 2023

Mar 01, 2023

Apr 03, 2023

Feb 28, 2023

Oct 27, 2022

MCK.NB Interim Cash Dividend of gross USD 0.54 paid on Jan 03, 2023 going ex on Nov 30, 2022

Dec 01, 2022

Jan 03, 2023

Nov 30, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

728.200USD

Mckesson Corp

728.200

Overview

Company